milk
contain
array
protein
use
bioactiv
mani
milk
protein
encompass
nativ
chemic
modifi
casein
lactoferrin
alphalactalbumin
betalactoglobulin
demonstr
antivir
activ
casein
alphalactalbumin
gain
antihiv
activ
modif
anhydrid
mani
milk
protein
inhibit
hiv
revers
transcriptas
bovin
glycolactin
lactogenin
casein
alphalactalbumin
betalactoglobulin
bovin
lactoferrampin
human
lactoferrampin
inhibit
proteas
integras
sever
mammalian
lactoferrin
prevent
hepat
c
infect
lactoferrin
methyl
alphalactalbumin
methyl
betalactoglobulin
inhibit
human
cytomegaloviru
chemic
modifi
alphalactalbumin
betalactoglobulin
lysozym
lactoferrin
lactoferricin
methyl
alphalactalbumin
methyl
ethyl
betalactoglobulin
inhibit
hsv
chemic
modifi
bovin
betalactoglobulin
antihuman
papillomaviru
activ
betalactoglobulin
lactoferrin
esterifi
betalactoglobulin
esterifi
lactoferrindisplay
antiavian
influenza
activ
lactoferrin
inhibit
respiratori
syncyti
viru
hepat
b
viru
adenoviru
polioviru
hantaviru
sindbi
viru
semliki
forest
viru
echoviru
enteroviru
milk
mucin
apolactoferrin
fe
betalactoglobulin
human
lactadherin
bovin
igg
bovin
kappacasein
demonstr
antihuman
rotaviru
activ
milk
colostrum
abund
sourc
protein
peptid
pivot
role
neonat
adult
milk
protein
peptid
potenti
healthenhanc
nutraceut
may
util
nutraceut
treatment
asthma
cancer
dental
diseas
diarrhea
hypertens
immunodefici
miner
malabsorpt
thrombosi
protein
peptid
milk
character
bioavail
safeti
lactoferrin
exhibit
antivir
antifung
antibacteri
antitumor
antiparasit
immunoenhanc
activ
lactoperoxidas
antibacteri
activ
lysozym
prevent
dental
decay
casein
hydrolyz
protect
bacteriemia
display
antitumor
activ
glycomacropeptid
deriv
kappacasein
exert
antithrombot
antibacteri
action
alphalactalbumin
possess
antivir
antitumor
anxiolyt
antistress
antidiarrhea
antihypertens
activ
prolinerich
polypeptid
enhanc
cell
matur
protect
autoimmun
diseas
zimecki
kruzel
kanwar
et
al
almehdar
et
al
intent
present
articl
review
antivir
effect
variou
whey
protein
differ
antivir
action
shown
fig
secretori
leukocyt
proteas
inhibitor
protein
found
milk
bodi
secret
like
saliva
inhibit
hiv
type
vitro
level
secretori
leukocyt
proteas
inhibitor
infant
saliva
correl
transmiss
overal
howev
among
breastf
babi
uninfect
month
elev
salivari
level
secretori
leukocyt
proteas
inhibitor
correl
reduc
risk
transmiss
breast
milk
farquhar
et
al
purifi
milk
mucin
crude
breast
milk
inhibit
vitro
habt
et
al
mthembu
et
al
crude
milk
surround
fat
globul
act
viru
liber
fat
globul
habt
et
al
angiogenin
milk
protein
ribonucleas
antihiv
activ
bedoya
et
al
cocchi
et
al
tenascinc
breast
milk
extracellular
matrix
protein
pivot
role
fetal
develop
wound
heal
neutral
bind
envelop
protein
chemokin
coreceptor
site
process
inhibit
loop
chemokin
coreceptor
bind
site
account
protect
breastf
babi
mucos
transmiss
fouda
et
al
chemic
modif
lysin
residu
casein
aromat
acid
anhydrid
trimellit
anhydrid
trimellit
anhydrid
chlorid
ensu
potent
inhibit
casein
bind
gp
envelop
glycoprotein
cell
receptor
due
bind
ii
infect
modifi
bovin
milk
protein
demonstr
potent
inhibit
may
potenti
use
prophylaxi
neurath
et
al
bovin
lactoferrin
apoform
form
satur
ferric
manganes
zinc
ion
potent
suppress
replic
syncytium
format
curtail
dna
cell
line
ad
prior
hiv
infect
viral
adsorpt
step
mechan
action
may
involv
inhibit
hiv
bind
entri
cell
although
postadsorpt
effect
elimin
puddu
et
al
polyanion
reagent
dextran
sulfat
heparin
sulfat
anion
protein
display
antihiv
activ
vitro
chemic
modif
product
betalactoglobulin
form
reaction
anhydrid
possess
consider
elev
hiv
inhibitori
activ
addit
anion
carboxyl
group
along
polypeptid
backbon
engend
repuls
within
protein
molecul
consequ
modif
secondari
tertiari
structur
produc
unstructur
protein
similarli
alpha
casein
alphalactalbumin
gain
antihiv
activ
modif
anhydrid
berkhout
et
al
unlik
chemic
modifi
milk
protein
unmodifi
alpha
beta
kappacasein
well
sever
neg
posit
charg
fragment
devoid
repress
effect
hiv
replic
bovin
lactoferrin
suppress
ic
lactoferricin
posit
charg
domain
bovin
lactoferrin
manifest
moder
inhibitori
activ
signifi
domain
lactoferrin
molecul
addit
lactoferricin
contribut
hiv
inhibitori
activ
bovin
lactoferrin
bovin
lactoferrin
suppress
variant
employ
either
coreceptor
order
elucid
mechan
action
bovin
lactoferrin
variant
demonstr
resist
milk
protein
util
viral
envelop
protein
harbor
two
mutat
associ
chang
virushost
interact
receptorcoreceptor
interact
play
role
resist
phenotyp
data
show
bovin
lactoferrin
target
entri
berkhout
et
al
two
peptid
compos
nine
amino
acid
human
lysozym
hl
correspond
residu
inhibit
infect
replic
ec
nm
similar
intact
lysozym
scrambl
sequenc
replac
tryptophan
arginin
residu
abrog
antivir
activ
sequenc
rawvawrnr
form
pocket
superfici
basic
residu
display
alphahel
structur
nativ
human
lysozym
region
separ
muramidas
catalyt
site
howev
tendenc
form
helix
show
correl
antivir
activ
reveal
mont
carlo
peptid
fold
energi
minim
simul
model
circular
dichroism
studi
peptid
modifi
gene
express
hivinfect
cell
impact
pathway
implic
stress
surviv
transform
growth
factorbeta
nf
kappab
protein
kinas
c
hedgehog
signal
leehuang
et
al
wang
et
al
assay
number
milk
protein
human
immunodefici
revers
transcriptas
alphaglucosidas
betaglucosidas
betaglucuronidas
inhibitori
activ
alphalactalbumin
betalactoglobulin
casein
display
hardli
inhibitori
effect
lactoferrin
demonstr
highest
inhibitori
potenc
lactoperoxidas
lactogenin
glycolactin
inhibit
rt
activ
reduc
potenc
alphalactalbumin
betalactoglobulin
casein
glycolactin
human
lactoferrin
exhibit
augment
inhibitori
effect
follow
succinyl
variou
milk
protein
littl
inhibitori
effect
activ
alphaglucosidas
betaglucosidas
betaglucuronidas
succinyl
enhanc
suppress
activ
milk
protein
alphaglucosidas
similar
effect
inhibitori
activ
toward
betaglucosidas
betaglucuronidas
wang
et
al
protein
ntermin
sequenc
resembl
polymer
immunoglobulin
receptor
revers
transcriptas
inhibitori
activ
isol
bovin
milk
ng
ye
although
alphalactalbumin
betalactoglobulin
casein
proteas
inhibitori
integras
inhibitori
activ
revers
transcriptas
inhibit
lactoferrin
potent
inhibitor
revers
transcriptas
proteas
inhibitori
integras
inhibitori
activ
low
glycolactin
mildli
inhibit
revers
transcriptas
power
suppress
proteas
integras
comparison
milk
protein
glycolactin
strongli
inhibit
proteas
integras
mildli
inhibit
revers
transcriptas
lactogenin
exert
mark
suppress
action
integras
revers
transcriptas
inhibitori
activ
proteas
inhibitori
activ
respect
moder
weak
ng
et
al
human
lactoferricin
potent
inhib
revers
transcriptas
ic
bovin
lactoferricin
bovin
lactoferrampin
deriv
bovin
lactoferrin
less
potent
ic
respect
human
lactoferrampin
human
bovin
lactoferrin
mm
concentr
devoid
inhibitori
effect
revers
transcriptas
peptid
manifest
weak
inhibitori
action
slightli
inhibit
proteas
human
bovin
lactoferrampin
inhibit
integras
significantli
respect
human
bovin
lactoferrampin
dosedepend
inhibit
integras
peptid
devoid
integras
inhibitori
activ
thu
lactoferrin
fragment
inhibit
revers
transcriptas
integras
wong
et
al
antihuman
cytomegaloviru
antihcmv
antiherp
simplex
viru
type
activ
introduct
posit
charg
lactoferrin
amin
led
enhanc
antihcmv
activ
fall
antihiv
activ
ntermin
part
lactoferrin
contribut
antihcmv
activ
swart
et
al
unmodifi
milk
protein
except
lactoferrin
devoid
inhibitori
activ
toward
hiv
hcmv
chemic
modif
endow
sever
milk
protein
polyanion
polycation
characterist
enabl
acquir
antihiv
activ
antihcmv
activ
respect
florisa
et
al
methyl
alphalactalbumin
methyl
betalactoglobulin
peptic
hydrolys
lpolylysin
attenu
infect
cytomegaloviru
fibroblast
reaction
alphalactalbumin
betalactoglobulin
lysozym
chemic
modif
agent
anhydrid
produc
compound
antivir
activ
toward
infect
devoid
activ
porcin
respiratori
corona
viru
bovin
parainfluenza
viru
type
peptic
tryptic
chymotrypt
digest
protein
yield
antihsv
fragment
oevermann
et
al
lactoferrin
lactoferricin
exhibit
synergist
action
acyclovir
effect
concentr
antivir
agent
milk
proteinpeptid
use
conjunct
acyclovir
could
reduc
appli
singli
andersen
et
al
lactoferrin
lactoferricin
thwart
entri
hsv
host
cell
jenssen
methyl
alphalactalbumin
methyl
ethyl
betalactoglobulin
peptic
hydrolyz
manifest
protect
action
albeit
less
potent
acyclovir
lpolylysin
test
acyclovirsensit
acyclovirresist
strain
use
fix
suspend
vero
cell
line
methyl
alphalactalbumin
inhibit
replic
shown
realtim
pcr
cell
expos
bovin
lactoferrin
also
cell
expos
bovin
lactoferricin
exhibit
mark
reduct
cellular
uptak
compar
control
cell
infect
treat
milk
protein
intern
viru
particl
exhibit
delay
intracellular
traffick
marr
et
al
lactoferrin
local
cell
surfac
cell
express
heparin
sulfat
lactoferricin
exhibit
random
intracellular
distribut
heparan
sulfat
cell
surfac
crucial
antivir
activ
lactoferrin
lactoferricin
order
manifest
antivir
action
lactoferrin
locat
cell
surfac
lactoferricin
present
insid
cell
andersen
et
al
lactoferrin
potent
inhibitor
human
herp
simplex
type
bovin
lactoferrin
inhibit
viral
infect
bind
heparin
sulfat
glycosaminoglycan
receptor
human
herpet
virus
antivir
action
bovin
lactoferrin
necessit
gcheparan
sulfat
interact
milk
protein
activ
wildtyp
viru
mutant
viru
mutant
viru
demonstr
higher
sensit
wildtyp
viru
human
lactoferrin
suggest
interact
human
lactoferrin
viral
structur
cover
gc
wildtyp
virus
bovin
lactoferrin
display
higher
efficaci
human
lactoferrin
infect
distinct
case
bovin
lactoferrin
suppress
plaqueform
activ
also
cell
express
glycosaminoglycan
find
suggest
bovin
milk
protein
may
block
viru
receptor
nonglycosaminoglycan
natur
marchetti
et
al
lactoferrin
lactoferricin
suppress
infect
gmk
cell
lactoferricin
lactoferrin
suppress
infect
vivo
lactoferricin
mix
inocul
diseas
develop
inhibit
viral
load
mous
model
genit
infect
reduc
product
chemokin
mous
splenocyt
vitro
affect
milk
protein
howev
test
vivo
lactoferrin
lactoferricin
elicit
vagin
product
lactoferrin
induc
product
neither
lactoferrin
lactoferricin
prevent
infect
administ
day
infect
lactoferricin
delay
onset
diseas
day
lower
viral
load
nearli
administ
day
infect
shestakov
et
al
lactoferrin
exert
antivir
action
earli
phase
hbv
infect
probabl
interact
host
cell
surfac
molecul
human
lactoferrin
seven
synthet
peptid
deriv
human
test
abil
inhibit
hbv
infect
replic
use
heparg
cell
line
four
peptid
elicit
inhibit
hbv
infect
heparg
cell
contain
grrrr
cation
cluster
exhibit
highest
potenc
grrrr
cation
cluster
one
two
glycosaminoglycan
bind
site
nativ
human
lactoferrin
associ
antivir
activ
mechan
action
fulllength
protein
distinct
preincub
peptid
viru
target
cell
inhibit
hbv
infect
posit
charg
cluster
peptid
enabl
interact
residu
virion
envelop
carri
opposit
charg
lack
second
glycosaminoglycan
bind
site
account
inabl
effici
adher
cell
may
hold
promis
interf
hbv
entri
neutral
viral
particl
florian
et
al
lactoferrin
interact
hcv
inhibit
hcv
infect
cultur
human
hepatocyt
preincub
cell
hbv
bovin
human
lactoferrin
inhibitori
effect
hbv
infect
bovin
transferrin
lactoalbumin
casein
devoid
antihbv
activ
hara
et
al
bovin
lactoferrin
lactoferricin
betalactoglobulinor
casein
inhibit
hcv
infect
human
liver
cell
suscept
hcv
infect
human
cell
direct
interact
hcv
inhibit
hcv
infect
lactoferrin
forestal
infect
hepat
g
viru
distant
rel
hcv
ikeda
et
al
camel
lactoferrin
exert
suppress
effect
hcv
entri
cell
directli
interact
viru
hcv
amplif
cell
n
c
lobe
camel
lactoferrin
manifest
antihcv
activ
cell
liao
et
al
human
lactoferrin
also
counterpart
cow
sheep
camel
interf
entri
hcv
cell
interact
directli
viru
rather
bring
chang
target
cell
well
reduc
viral
amplif
cell
infect
hcv
camel
lactoferrin
potent
elfakharani
et
al
nlobe
fragment
camel
lactoferrin
possess
higher
antihcv
activ
camel
lactoferrin
activ
clobe
fragment
camel
lactoferrin
redwan
et
al
lactoferrin
suppress
adenoviru
infect
bind
adenoviru
particl
compet
common
glycosaminoglycan
receptor
target
viral
iii
iiia
structur
polypeptid
pietrantoni
et
al
lactoferrin
alphalactalbumin
betalactoglobulin
mucin
repress
adenoviru
replic
lactoferrin
capabl
inhibit
viral
replic
prior
viral
adsorpt
step
throughout
adenoviru
replic
cycl
henc
lactoferrin
exert
action
earli
phase
viral
replic
arnold
et
al
antivir
efficaci
bovin
lactoferrin
ribavirin
determin
seoul
type
hantaviru
strain
vitro
hantavir
foci
number
vero
cell
infect
underw
declin
exposur
lactoferrin
day
follow
infect
obtain
effect
dose
preexposur
lactoferrin
highli
effect
yield
howev
preexposur
ribavirin
h
produc
inhibit
viral
focu
format
decreas
number
viral
foci
ed
use
time
viral
infect
preexposur
cell
monolay
lactoferrin
h
follow
addit
ribavirin
disclos
synerg
action
lactoferrin
ribavirin
exposur
lactoferrin
h
prior
cell
inocul
yield
rins
lactoferrinpretr
cell
monolay
phosphatebuff
salin
demonstr
minim
decreas
foci
indic
light
attach
lactoferrin
cell
murphi
et
al
subsequ
antihantavir
mechan
action
bovin
lactoferrin
ribavirin
elucid
hantaviru
focu
format
h
control
valu
cell
expos
lactoferrin
h
viral
infect
control
valu
cell
expos
ribavirin
viral
infect
hantaviru
focu
format
total
abolish
preinfect
exposur
lactoferrin
postinfect
exposur
ribavirin
synthesi
viral
glycoprotein
nucleocapsid
protein
postpon
lactoferrinpretr
cell
postinfect
becam
similar
control
valu
postinfect
lactoferrin
suppress
viral
shed
h
postinfect
lactoferrin
hinder
viral
adsorpt
cell
hand
ribavirin
interfer
viral
rna
synthesi
effect
preinfect
exposur
lactoferrin
postinfect
exposur
ribavirin
hantavirusinfect
suckl
mice
investig
preinfect
exposur
lactoferrin
mgkg
day
challeng
viru
increas
surviv
rate
respect
day
challeng
viru
ribavirin
concentr
mgkg
yield
surviv
rate
respect
henc
lactoferrin
ribavirin
effect
prevent
hantaviru
infect
vivo
murphi
et
al
lactoferrin
inhibit
infect
babi
hamster
kidney
cell
heparin
sulfateadapt
nonadapt
sindbi
viru
semliki
forest
viru
lactoferrin
also
inhibit
bind
radiolabel
heparin
sulfateadapt
virus
cell
liposom
contain
lipidconjug
heparin
receptor
analog
howev
viral
fusion
liposom
induc
lowph
take
place
independ
virusreceptor
interact
unalt
preincub
viru
cell
lactoferrin
disclos
lactoferrin
block
heparin
sulfat
moieti
cell
surfac
bind
viru
antivir
activ
lactoferrin
associ
cation
characterist
sinc
human
serum
albumin
acquir
cation
characterist
charg
modif
display
analog
antivir
activ
heparin
sulfateadapt
sindbi
viru
semliki
forest
viru
thu
human
lactoferrin
interfer
virusreceptor
interact
therebi
inhibit
viral
infect
waart
et
al
lactoferrin
esterifi
esterifi
lactoferrin
manifest
antivir
activ
hpai
strain
clade
latter
two
protein
potent
esterifi
exhibit
weak
antivir
activ
taha
et
al
lactoferrin
lactoperoxidas
administ
gavag
mitig
pneumonia
mice
infect
intranas
influenza
viru
serum
concentr
proinflammatori
number
infiltr
leukocyt
bronchoalveolar
lavag
fluid
fell
although
effect
viru
yield
lavag
fluid
shin
et
al
mdck
cell
infect
influenza
viru
subtyp
upon
exposur
methyl
demonstr
fall
hemagglutin
activ
inhibit
viru
escort
protect
mdck
cell
viru
treat
methyl
absenc
mdck
cell
diminut
intact
viru
particl
viral
viabil
well
deleteri
chang
ultrastrctur
appear
viru
particl
main
subtyp
influenza
viru
includ
inhibit
bovin
lactoferrin
clobe
nlobe
help
molecular
dock
found
three
fragment
clobe
bound
ha
region
viral
hemagglutinin
suppress
viral
hemagglutin
infect
fentomolar
concentr
ammendolia
et
al
bovin
lactoferrin
suppress
cytopath
effect
brought
influenza
viru
incub
cell
adsorpt
step
activ
unrel
ion
satur
carbohydr
content
milk
protein
lactoferrin
demonstr
antivir
activ
respiratori
syncyti
viru
vitro
vivo
mous
model
whether
true
infant
risk
infect
respiratori
syncyti
viru
await
elucid
gualdi
et
al
pronounc
inhibitori
activ
anhydridemodifi
bovin
betalactoglobulin
human
papillomavirus
includ
report
antihpv
activ
show
correl
percentag
modifi
lysin
arginin
residu
modifi
milk
protein
show
cytotox
mgml
stabil
room
temperatur
least
month
note
henc
promis
candid
develop
antihpv
agent
nativ
bovin
lactoferrin
especi
lactoferrin
complet
digest
gastric
phase
ph
reduc
suppress
echoviru
vitro
ad
prior
concomitantli
viru
onto
cell
bovin
lactoferrin
may
prevent
infect
gastrointestin
viru
furlund
et
al
bovin
lactoferrin
thwart
echoviru
cytopath
effect
antigen
synthesi
suppress
viral
replic
prior
subsequ
viral
adsorpt
step
lactoferricin
also
imped
viral
bind
pietrantoni
et
al
enteroviru
type
etiolog
agent
handfootandmouth
diseas
recombin
porcin
lactoferrin
express
milk
transgen
mice
protect
pup
infect
chen
et
al
bovin
lactoferrin
suppress
polioviru
infect
monkey
embryo
kidney
cell
attach
surfac
suscept
cell
inhibit
viral
adhes
henc
lactoferrin
use
combat
foodborn
infect
caus
enter
virus
like
polioviru
mccann
et
al
bovin
human
lactoferrin
alphalactalbumin
betalactoglobulin
mucin
prevent
polioviru
infect
vero
cell
apolactoferrin
nativ
lactoferrin
lactoferrin
fulli
satur
ferric
manganes
zinc
ion
inhibit
viral
replic
throughout
polioviru
infect
cycl
viral
adsorpt
zinc
lactoferrin
potent
suppress
viral
infect
incub
cell
follow
viral
attach
inhibit
show
posit
correl
extent
zinc
satur
aforement
lactoferrin
act
earli
phase
polioviru
infect
zinc
lactoferrin
form
lactoferrin
could
suppress
infect
stage
viral
intern
host
cell
marchetti
et
al
elev
titer
antirotaviru
antibodi
detect
camel
milk
lactoperoxidas
system
inhibitori
effect
rotaviru
elagami
et
al
complex
human
milk
glycoprotein
mucin
elev
level
antirotaviru
activ
declin
deglycosyl
human
milk
mucin
bound
rotaviru
suppress
viral
replic
vitro
vivo
yolken
et
al
apolactoferrin
fe
lactoferrin
betalactoglobulin
suppress
rotaviru
replic
apolactoferrin
exhibit
highest
activ
apolactoferrin
bound
viral
particl
imped
viral
attach
cell
receptor
suppress
rotaviru
hemagglutin
bind
human
enterocytelik
cell
apolactoferrin
exert
inhibitori
effect
earli
phase
rotaviru
infect
undermin
rotavir
antigen
synthesi
yield
cell
viral
adsorpt
earli
hour
infect
superti
et
al
rotaviru
caus
gastroenter
infant
may
result
sever
even
fatal
dehydr
lactadherin
milk
fat
globul
protein
may
contribut
higher
protect
breastf
children
infect
human
lactadherin
attenu
infect
rotaviru
bovin
bovin
macromolecular
whey
protein
fraction
bovin
igg
main
constitu
also
activ
reduc
infect
mous
emcn
rotaviru
strain
indic
viral
shed
stool
inhibit
appear
viral
antibodi
serumin
adult
balbc
mice
bojsen
et
al
mechan
suppress
action
bovin
hrventail
bind
viru
particl
glycan
residu
thermolabil
structur
may
contribut
mainten
bind
hrv
inagaki
et
al
forego
account
seen
divers
whey
protein
exhibit
antivir
activ
tabl
sometim
chemic
modif
antivir
action
express
larg
number
virus
pathogen
human
includ
human
immunodefici
viru
human
cytomegaloviru
hepat
c
viru
avian
influenza
influenza
viru
subtyp
respiratori
syncyti
viru
herp
simplex
viru
type
type
human
papillomaviru
human
echoviru
enteroviru
human
rotaviru
possibl
milk
protein
also
activ
virus
explor
date
investig
conduct
like
list
milk
protein
activ
particular
viru
expand
milk
protein
test
antivir
activ
toward
differ
virus
instanc
whether
apolipoprotein
hlike
milk
protein
lactoribonucleas
lactogenin
glycolactin
ye
et
al
ye
ng
b
c
antivir
activ
await
elucid
presenc
multitud
antimicrobi
protein
milk
endow
milk
healthpromot
antipathogen
properti
regular
consumpt
milk
recommend
nutritionist
physician
fact
milk
formula
fortifi
lactoferrin
intent
promot
health
mani
milk
protein
lactoferrin
valuabl
nutracet
advantag
milk
protein
good
bioavail
safeti
retain
activ
presenc
proteolyt
enzym
known
whether
variou
milk
protein
manifest
synergist
action
potenti
action
antivir
therapeut
demonstr
milk
protein
especi
case
bovin
lactoferrin
viani
et
al
would
facilit
synergist
effect
antivir
drug
lower
drug
dosag
use
combin
therapi
reduc
likelihood
develop
drugresist
mutant
cytotox
due
lower
dosag
requir
antivir
drug
andersen
et
al
usual
antivir
mechan
milk
protein
antivir
agent
distinctli
differ
inhibit
differ
step
viral
replic
cycl
van
der
strate
et
al
lactoferrin
antimicrobi
properti
bacteria
fungi
sever
virus
neurath
et
al
berkhout
et
al
bovin
lactoferrin
lactoferricin
block
viral
entri
host
cell
attach
berkhout
et
al
bovin
lactoferrin
apoform
form
satur
ferric
manganes
zinc
ion
suppress
replic
syncytium
format
inhibit
viral
bind
entri
host
cell
puddu
et
al
secretori
leukocyt
proteas
inhibitor
inhibit
replic
farquhar
et
al
peptid
compos
residu
human
lysozym
disrupt
viral
particl
prevent
bind
entri
target
cell
leehuang
et
al
angiogenin
inhibit
replic
bedoya
et
al
cocchi
et
al
milk
mucin
inhibit
infectionbi
physic
aggreg
viru
charg
interact
neg
charg
carbohydr
side
chain
contain
highsial
acid
sulphat
content
habt
et
al
mthembu
et
al
tenascinc
neutral
bind
viral
envelop
protein
chemokin
coreceptor
site
fouda
et
al
human
cytomegaloviru
lactoferrin
block
viral
replic
swart
et
al
methyl
methyl
interact
viral
genom
dna
perturb
replic
transcript
activ
viru
herp
simplex
viru
type
chemic
modifi
lysozym
inhibit
multipl
oevermann
et
al
lactoferrin
inhibit
first
step
hsv
infect
exhibit
synergist
effect
combin
therapi
acyclovir
andersen
et
al
lactoferrin
lactoferricin
inhibit
hsv
replic
entri
host
cell
jenssen
andersen
et
al
marr
et
al
methyl
methyl
ethyl
inhibit
interact
viral
cellular
protein
limit
viru
entri
protect
cell
hepat
b
viru
human
lactoferrin
synthet
derivativespeptid
inhibit
viral
entri
neutral
viral
particl
florian
et
al
human
bovin
lactoferrin
interfer
viral
attach
entri
hara
et
al
hepat
c
viru
bovin
lactoferrin
neutral
viru
block
invas
host
cell
ikeda
et
al
human
cow
sheep
camel
lactoferrin
interact
viru
suppress
viral
entri
amplif
host
cell
liao
et
al
gualdi
et
al
human
papillomaviru
chemic
modifi
bovin
inhibit
earli
stage
viral
replic
particularli
viral
entri
process
human
echoviru
bovinelactoferrin
lactoferrin
inhibit
viral
bind
exhibit
cytopath
effect
antigen
synthesi
inhibit
viral
replic
prior
subsequ
viral
adsorpt
step
pietrantoni
et
al
furlund
et
al
enteroviru
porcin
lactoferrin
block
adsorpt
receptormedi
bind
viru
target
cell
membran
chen
et
al
polioviru
bovin
lactoferrin
target
viral
adsorpt
bind
surfac
host
cell
prevent
attach
viru
particl
compet
viral
receptor
interact
mccann
et
al
marchetti
et
al
human
rotaviru
milk
mucin
bind
rotaviru
suppress
viralrepl
yolken
et
al
apolactoferrin
fe
lactoferrin
bind
viral
particl
imped
viral
attach
cell
receptor
suppress
rotaviru
hemagglutin
bind
cellular
receptor
superti
et
al
human
lactadherin
bovin
igg
inhibit
rotaviru
infect
bojsen
et
al
bovin
bind
viru
particl
glycan
residu
inagaki
et
al
herp
simplex
viru
type
echoviru
enteroviru
human
rotaviru
reader
interest
antivir
properti
lactoferrin
may
consult
good
review
van
der
strate
et
al
mechan
antivir
action
milk
protein
uncov
virus
also
remain
elucid
whether
aforement
differ
antivir
effect
demonstr
anim
model
infect
virus
sinc
fragment
lactoferrin
like
lactoferricin
high
potenc
biolog
activ
fragment
milk
protein
may
likewis
consider
antivir
activ
chemic
synthes
use
instead
parent
milk
protein
great
deal
effort
direct
search
natur
product
suppress
activ
variou
virus
harnett
et
al
tshikalang
et
al
klo
et
al
ghosh
et
al
chen
et
al
mulder
et
al
shin
et
al
alfajaro
et
al
wang
et
al
xu
et
al
dang
et
al
milk
combin
protein
activ
divers
virus
thu
milk
potenti
therapeut
applic
well
good
nutrit
valu
